P28504 (HIR2_HIRME) Hirudo medicinalis (Medicinal leech)
Hirudin-2 UniProtKBInterProInteractive Modelling
65 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
58 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| STRUCTURE OF THE HIRULOG 3-THROMBIN COMPLEX AND NATURE OF THE S' SUBSITES OF SUBSTRATES AND INHIBIT… |
Heteromer P00734; | 63.16 | ||||
| CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ALPHA-THROMBIN AND NON-HYDROLYZABLE BIFUNCTIONAL INHIBITO… |
Heteromer P00734; | 100 | ||||
| Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine P… |
Heteromer P00734; | 100 | 1×NA; 1×696; | |||
| A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK … |
Heteromer P00734; | 100 | 1×ZN; 1×CA; 1×NA; 1×BMZ; | |||
| Crystal Structure of Thrombin in complex with compound17 |
Heteromer P00734; | 100 | 1×N6H; 1×NAG; 1×DMS; | |||
| Crystal structure of human alpha-thrombin*RWJ-51438 complex at 1.7 A |
Heteromer P00734; | 100 | 1×1Z0; 1×NAG; 2×NA; | |||
| Crystal Structure of Thrombin in complex with compound51 |
Heteromer P00734; | 100 | 1×QQT; 1×NAG; | |||
| SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN |
Heteromer P00734; | 100 | 1×NA; 1×130; | |||
| Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala1… |
Heteromer P00734; | 100 | 1×NA; 1×CA; 1×CR9; | |||
| RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
Heteromer P00734; | 100 | 1×ZN; 1×NA; 1×BAI; | |||
| A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK … |
Heteromer P00734; | 100 | 1×NA; 1×BMZ; | |||
| Crystal Structure of Thrombin in complex with compound20a |
Heteromer P00734; | 100 | 1×QQ5; 1×NAG; | |||
| thrombin in complex with selective macrocyclic inhibitor at 1.8A |
Heteromer P00734; | 90.91 | 1×L86; | |||
| Crystal Structure of Thrombin in complex with compound10 |
Heteromer P00734; | 100 | 1×QPW; 1×NAG; | |||
| CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE-MIMETIC INHIBITOR |
Heteromer P00734; | 100 | 1×PPX; | |||
| COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG1 |
Heteromer P00734; | 100 | 1×T29; | |||
| SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN |
Heteromer P00734; | 100 | 1×NA; 1×132; | |||
| COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG2 |
Heteromer P00734; | 100 | 1×T16; | |||
| A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK … |
Heteromer P00734; | 100 | 1×NA; 1×120; | |||
| A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK … |
Heteromer P00734; | 100 | 3×ZN; 1×NA; 1×CA; 1×121; | |||
| STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKI… |
Heteromer P00734; | 100 | 1×NA; 1×BEN; | |||
| RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
Heteromer P00734; | 100 | 3×ZN; 1×NA; 1×BAH; | |||
| Crystal structure of thrombin in complex with compound 14b |
Heteromer P00734; | 81.82 | 1×177; | |||
| Crystal structure of Thrombin in complex with compound30 |
Heteromer P00734; | 100 | 1×QQN; 1×NAG; | |||
| Crystal Structure of Thrombin in complex with compound42a |
Heteromer P00734; | 100 | 1×QQE; 1×NAG; | |||
| Crystal Structure of Thrombin in complex with compound42b |
Heteromer P00734; | 100 | 1×NAG; 1×QQW; | |||
| RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
Heteromer P00734; | 100 | 2×ZN; 1×NA; 1×BAB; | |||
| Crystal Structure of Thrombin in Complex with L-378,622 |
Heteromer P00734; | 100 | 1×CDA; | |||
| Thrombin-Hirugen-L405,426 |
Heteromer P00734; | 100 | 1×CDD; | |||
| Crystal Structure Analysis of a novel Oxyguanidine bound to Thrombin |
Heteromer P00734; | 100 | 1×81A; | |||
| Crystal Structure Analysis of a novel Oxyguanidine bound to Thrombin |
Heteromer P00734; | 100 | 1×14A; | |||
| Crystal Structure of Thrombin in complex with compound40 |
Heteromer P00734; | 100 | 1×QQK; 1×NAG; | |||
| thrombin in complex with selective macrocyclic inhibitor |
Heteromer P00734; | 81.82 | 1×T76; | |||
| Cyanofluorophenylacetamides as Orally Efficacious Thrombin Inhibitors |
Heteromer P00734; | 100 | 1×DKK; | |||
| CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERE… |
Heteromer P00734; P01050; | 100 | 1×NAG; | |||
| Crystal structure of thrombin in complex with compound 1 |
Heteromer P00734; | 81.82 | 1×176; | |||
| CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTI… |
Heteromer P00734; | 100 | 1×MID; | |||
| CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTI… |
Heteromer P00734; | 100 | 1×MIT; | |||
| CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTI… |
Heteromer P00734; | 100 | 1×BEN; | |||
| Human alpha-thrombin-Bivalirudin complex at PD5.0 |
Heteromer P00734; | 100 | 1×NAG; | |||
| STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKI… |
Heteromer P00734; | 100 | 1×NA; 1×CA; 1×ESI; | |||
| thrombin and P2 pyridine N-oxide inhibitor complex structure |
Heteromer P00734; | 100 | 1×L17; | |||
| crystal structue of Thrombin in complex with a potent P1 heterocycle-Aryl based inhibitor |
Heteromer P00734; | 100 | 1×170; | |||
| THROMBIN INHIBITOR COMPLEX |
Heteromer P00734; | 100 | 1×R11; | |||
| Thrombin in complex with an azafluorenyl inhibitor 23b |
Heteromer P00734; | 100 | 1×062; | |||
| THROMBIN INHIBITOR COMPLEX |
Heteromer P00734; | 100 | 1×T87; | |||
| Thrombin in complex with natural product inhibitor Oscillarin |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×OSC; | |||
| Thrombin inhibitor complex |
Heteromer P00734; | 100 | 1×C02; | |||
| Human alpha thrombin inhibited by RPPGF and hirugen |
Heteromer P00734; P01042; | 100 | ||||
| ACTIVE SITE MIMETIC INHIBITION OF THROMBIN |
Heteromer P00734; | 100 | 1×0ZI; | |||
| Thrombin Inhibitor Complex |
Heteromer P00734; | 100 | 1×C24; | |||
| Crystal structure of the thrombin mutant D221A/D222K |
Heteromer P00734; | 90.0 | 1×NAG; | |||
| Thrombin in complex with inhibitor |
Heteromer P00734; | 90.0 | 1×NA; 1×G44; | |||
| X/N Joint refinement of Human alpha-thrombin-Bivalirudin complex PD5 |
Heteromer P00734; | 100 | 1×NAG; | |||
| Novel Non-Covalent Thrombin Inhibitors Incorporating P1 4,5,6,7-Tetrahydrobenzothiazole Arginine Si… |
Heteromer P00734; | 100 | 2×NA; 1×165; | |||
| SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. |
Heteromer P00734; | 75.0 | 1×NA; 1×IH1; | |||
| Complex of thrombin with designed inhibitor 7165 |
Heteromer P00734; | 100 | 1×SHY; 1×NA; 1×CA; | |||
| STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN |
Heteromer P00734; | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7a0e.1.B | monomer | 0.75 | 87.69 | |||